US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PMGC Holdings

2.53

+0.14005.86%

Volume:5.85M

Turnover:16.84M

Market Cap:2.24M

PE:-0.03

High:3.20

Open:2.55

Low:2.46

Close:2.39

Loading ...

Overview Company News Filings

ELEVAI Labs Inc. Ends License Agreement with INmune

Pmgc Holdings Inc - Co and INmune Bio Terminate License Agreement

THOMSON REUTERS

Pmgc Holdings Inc. Expands Investment & M&a Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of Tca Venture Group

THOMSON REUTERS

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

PMGC highlights ‘strong’ capital position

Pmgc Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

THOMSON REUTERS

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Northstrive Biosciences Submits Pre-IND Request for EL-22

Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Announces Successful Submission of Pre-Ind Meeting Request to FDA for El-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1 Receptor Agonists

THOMSON REUTERS

Northstrive Biosciences- Pre-Ind Meeting With FDA Expected in Q2 2025

THOMSON REUTERS

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists

PMGC files to sell 969,386 shares of common stock for holders

Northstrive Biosciences Unveils Innovative Obesity Drug Candidates

Northstrive - Anticipates Type B Pre-Ind Meeting With FDA in Q2 2025

THOMSON REUTERS

Pmgc Unit, Northstrive, Says Preparing for FDA Investigational New Drug Filing for El-22

THOMSON REUTERS

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

BRIEF-PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co's

Pmgc Capital Llc, a Subsidiary of Pmgc Holdings Inc., Begins to Build Portfolio With Strategic Acquisition of Shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

THOMSON REUTERS

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Signs Agreement for Preclinical Mouse Study of El-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELAB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":2.53,"timestamp":1746210861006,"preClose":2.39,"halted":0,"volume":5846115,"delay":0,"floatShares":768300,"shares":884400,"eps":-78.48178,"marketStatus":"Trading","change":0.14,"latestTime":"05-02 14:34:31 EDT","open":2.55,"high":3.2,"low":2.46,"amount":16838003.80746,"amplitude":0.309623,"askPrice":2.55,"askSize":20,"bidPrice":2.51,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-78.48178,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":2.58,"preClose":2.39,"latestTime":"09:29 EDT","volume":626504,"amount":1697313.7982808,"timestamp":1746192597043},"postHourTrading":{"tag":"盘后","latestPrice":2.6,"preClose":2.39,"latestTime":"19:59 EDT","volume":114177,"amount":287976.3013,"timestamp":1746143983286},"volumeRatio":23.128378},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","floatShares":768300,"roa":"-30.40%","roe":"-76.61%","lyrEps":-78.481779,"volumeRatio":23.128378,"shares":884400,"dividePrice":0,"high":3.2,"amplitude":0.309623,"preClose":2.39,"low":2.46,"week52Low":2.14,"pbRate":"0.34","psRate":"0.91","week52High":1064,"institutionHeld":0,"latestPrice":2.53,"committee":0.666667,"eps":-78.48178,"divideRate":0,"volume":5846115,"delay":0,"ttmEps":-78.48178,"open":2.55,"prevYearClose":16.03,"prevWeekClose":2.26,"prevMonthClose":2.29,"prevQuarterClose":4.63,"fiveDayClose":2.26,"twentyDayClose":4.42,"sixtyDayClose":12.25},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELAB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516662525","title":"ELEVAI Labs Inc. Ends License Agreement with INmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2516662525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516662525?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:31","pubTimestamp":1741041062,"startTime":"0","endTime":"0","summary":"ELEVAI Labs Inc. ( ($ELAB) ) has provided an announcement. PMGC Holdings Inc. had previously entered into a License Agreement with INmune Bio, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-ends-license-agreement-with-inmune?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-ends-license-agreement-with-inmune?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2516566143","title":"Pmgc Holdings Inc - Co and INmune Bio Terminate License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2516566143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516566143?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:10","pubTimestamp":1741039800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2514580126","title":"Pmgc Holdings Inc. Expands Investment & M&a Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of Tca Venture Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2514580126","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514580126?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUAC00X3G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2514380430","title":"PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380430","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514380430?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Feb. 27, 2025  -- PMGC Holdings Inc.  , a diversified holding company, is proud to announce its annual sponsorship of TCA Venture Group’s  Orange County network for 2025. As a Southern California Network Sponsor, PMGC is actively pursuing investments and M&A opportunities to strengthen its portfolio while fostering local business growth and expanding its market presence.“We are excited to join forces with TCA Venture Group as a key sponsor,” said Graydon Bensler, CFA, Chief Executive Officer of PMGC. “This sponsorship aligns perfectly with our mission to identify and support high-potential companies, providing both capital and operational expertise to drive long-term growth. TCA’s vast network of investors, entrepreneurs, and industry experts will enhance our ability to expand our portfolio and execute our acquisition strategy while directly contributing to the thriving Southern California business ecosystem.”Through this sponsorship, PMGC will gain valuable expo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pmgc-holdings-inc-expands-investment-130000815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELAB"],"gpt_icon":0},{"id":"2514858588","title":"PMGC highlights ‘strong’ capital position","url":"https://stock-news.laohu8.com/highlight/detail?id=2514858588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514858588?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:36","pubTimestamp":1740576967,"startTime":"0","endTime":"0","summary":"PMGC (ELAB) Holdings highlighting its financial position and ongoing commitment to executing its strategic priorities through its operating subsidi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmgc-highlights-strong-capital-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmgc-highlights-strong-capital-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2514830641","title":"Pmgc Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514830641?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:30","pubTimestamp":1740576601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA5FVCPH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2514183070","title":"PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2514183070","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514183070?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:30","pubTimestamp":1740576600,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Feb.  26, 2025  (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company,” “PMGC,” “us,” or “we”) (Nasdaq:ELAB), a diversified holding company, today announced an update on its capi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032923/0/en/PMGC-Holdings-Highlights-Strong-Capital-Position-No-Debt-Fully-Funded-and-Warrants-Priced-Above-Market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2512437819","title":"Northstrive Biosciences Submits Pre-IND Request for EL-22","url":"https://stock-news.laohu8.com/highlight/detail?id=2512437819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512437819?lang=en_us&edition=fundamental","pubTime":"2025-02-20 05:34","pubTimestamp":1740000891,"startTime":"0","endTime":"0","summary":"ELEVAI Labs Inc. ( ($ELAB) ) has provided an announcement. On February 18, 2025, Northstrive Biosciences announced the successful submission of a p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-submits-pre-ind-request-for-el-22?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-submits-pre-ind-request-for-el-22?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU2552382215.SGD","LU2552382058.USD","BK4585","LU0690374961.EUR","LU2552382132.HKD","BK4183","BK4504","EL","LU2404859667.USD","LU2404859741.USD","LU0690374615.EUR","BK4548","BK4558","ELAB","BK4588"],"gpt_icon":0},{"id":"2512815677","title":"Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Announces Successful Submission of Pre-Ind Meeting Request to FDA for El-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1 Receptor Agonists","url":"https://stock-news.laohu8.com/highlight/detail?id=2512815677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512815677?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:01","pubTimestamp":1739880074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P80ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2512567291","title":"Northstrive Biosciences- Pre-Ind Meeting With FDA Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512567291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512567291?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:01","pubTimestamp":1739880074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P80ZZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2512823159","title":"Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists","url":"https://stock-news.laohu8.com/highlight/detail?id=2512823159","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512823159?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:00","pubTimestamp":1739880000,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences Inc. (“Northstrive Biosciences”) has submitted a pre-Investigational New Drug (“pre-IND”) meeting request to the U.S. Food and Drug Administration (“FDA”) for EL-22, a novel my","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027670/0/en/Northstrive-Biosciences-Inc-a-Subsidiary-of-PMGC-Holdings-Inc-Announces-Successful-Submission-of-Pre-IND-Meeting-Request-to-FDA-for-EL-22-a-Potential-Breakthrough-Obesity-Therapy-T.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","LU2404859667.USD","BK4504","BK4144","LU0690374961.EUR","BK4588","LU0690374615.EUR","LU2552382058.USD","BK4183","LU2552382215.SGD","EL","BK4590","BK4585","LU2404859741.USD","LU2552382132.HKD","BK4548","BK4558","GLP","BK4533"],"gpt_icon":0},{"id":"2510327186","title":"PMGC files to sell 969,386 shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2510327186","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510327186?lang=en_us&edition=fundamental","pubTime":"2025-02-12 19:25","pubTimestamp":1739359510,"startTime":"0","endTime":"0","summary":"06:24 EST PMGC (ELAB) files to sell 969,386 shares of common stock for holders Published first on TheFly – the ultimate source for real-time, marke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmgc-files-to-sell-969386-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmgc-files-to-sell-969386-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2509774879","title":"Northstrive Biosciences Unveils Innovative Obesity Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774879","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509774879?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:32","pubTimestamp":1738963976,"startTime":"0","endTime":"0","summary":"An update from ELEVAI Labs Inc. ( ($ELAB) ) is now available. On February 7, 2025, Northstrive Biosciences presented its innovative obesity drug ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-unveils-innovative-obesity-drug-candidates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-unveils-innovative-obesity-drug-candidates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2508456532","title":"Northstrive - Anticipates Type B Pre-Ind Meeting With FDA in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456532?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:01","pubTimestamp":1738674099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nFWN3OV165:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2508456306","title":"Pmgc Unit, Northstrive, Says Preparing for FDA Investigational New Drug Filing for El-22","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456306?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:01","pubTimestamp":1738674099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nFWN3OV165:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2508245654","title":"Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2508245654","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508245654?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:00","pubTimestamp":1738674000,"startTime":"0","endTime":"0","summary":"Lead asset EL-22 is leveraging a myostatin-engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.Northstrive Biosciences Inc. is preparing the necessary steps to leverage existing EL-22 animal data and human safety studies from Korean licensing partner to arrange an Investigational New Drug filing with the U.S. Food and Drug Administration.EL-32 is a pre-clinical, engineered probiotic expressing dual myostatin & activin-A, focusing on two clinically validated targets that play an important role in regulating muscle.NEWPORT BEACH, Calif., Feb. 04, 2025  -- Northstrive Biosciences Inc. , a subsidiary of PMGC Holdings Inc.  , announced an update for its innovative obesity treatment candidates, EL-22 and EL-32, both aimed at optimizing fat loss while preserving muscle mass in patients undergoing weight loss therapies, including GLP-1 receptor agonists.Upon regulatory confirmation, Northstriv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-inc-subsidiary-pmgc-130000839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","BK4183","BK4590","ELAB","GLP"],"gpt_icon":1},{"id":"2508962253","title":"BRIEF-PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co's","url":"https://stock-news.laohu8.com/highlight/detail?id=2508962253","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508962253?lang=en_us&edition=fundamental","pubTime":"2025-02-01 00:21","pubTimestamp":1738340464,"startTime":"0","endTime":"0","summary":"BRIEF-PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co'sJan 31 (Reuters) - PMGC Holdings Inc ELAB.O:PMGC CAPITAL LLC, A SUBSIDIARY OF PMGC HOLDINGS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OR0RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2507612309","title":"Pmgc Capital Llc, a Subsidiary of Pmgc Holdings Inc., Begins to Build Portfolio With Strategic Acquisition of Shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2507612309","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507612309?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:35","pubTimestamp":1738337726,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OR0RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2507296128","title":"PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2507296128","media":"GlobeNewswire","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507296128?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:33","pubTimestamp":1738337580,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Jan.  31, 2025  (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC”) (Nasdaq: ELAB) is pleased to announce that its operating investment division, PMGC Capital LLC, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/31/3018887/0/en/PMGC-Capital-LLC-a-subsidiary-of-PMGC-Holdings-Inc-Begins-to-Build-Portfolio-with-Strategic-Acquisition-of-shares-in-U-S-Focused-Uranium-Energy-and-Fire-Prevention-Technology-Compa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4156","UEC","BGSX"],"gpt_icon":0},{"id":"2507864078","title":"Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Signs Agreement for Preclinical Mouse Study of El-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2507864078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507864078?lang=en_us&edition=fundamental","pubTime":"2025-01-30 21:00","pubTimestamp":1738242002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA3MNNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":119,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"ELAB","defaultRemindTime":1741613400000,"type":"split","dateTimestamp":1741579200000,"forFactor":7,"toFactor":1,"ratio":7},{"market":"US","date":"2024-11-27","symbol":"ELAB","defaultRemindTime":1732717800000,"type":"split","dateTimestamp":1732683600000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELAB","date":"2025-05-01","current":-0.25926,"percent":0.955752,"low":-19.933298,"twenty":-3.227399,"median":-1.420416,"eighty":-0.675686,"high":-0.185003,"avg":-2.607938,"sd":3.178605,"marketCap":1619272},"quantilePoints":[{"date":"2023-11-24","current":-18.255744,"twenty":-17.959705,"median":-17.515646,"eighty":-17.071587,"marketCap":64119575},{"date":"2023-12-01","current":-13.864497,"twenty":-19.360956,"median":-18.255744,"eighty":-16.918634,"marketCap":48696218},{"date":"2023-12-08","current":-10.509387,"twenty":-18.255744,"median":-15.443372,"eighty":-11.703412,"marketCap":36912079},{"date":"2023-12-15","current":-8.308155,"twenty":-18.10279,"median":-11.940243,"eighty":-9.335099,"marketCap":31539899},{"date":"2023-12-22","current":-8.354717,"twenty":-17.34789,"median":-10.682077,"eighty":-8.450306,"marketCap":31716661},{"date":"2023-12-29","current":-8.216856,"twenty":-16.918634,"median":-10.164008,"eighty":-8.299025,"marketCap":31193307},{"date":"2024-01-05","current":-7.303872,"twenty":-15.709807,"median":-9.153506,"eighty":-8.280766,"marketCap":27727384},{"date":"2024-01-12","current":-8.125558,"twenty":-14.012516,"median":-8.832664,"eighty":-8.070779,"marketCap":30846714},{"date":"2024-01-19","current":-4.884465,"twenty":-13.479646,"median":-8.376629,"eighty":-7.906442,"marketCap":18542688},{"date":"2024-01-26","current":-3.42369,"twenty":-11.881035,"median":-8.330979,"eighty":-7.359564,"marketCap":12997211},{"date":"2024-02-02","current":-3.834533,"twenty":-11.486317,"median":-8.216856,"eighty":-4.738387,"marketCap":14556876},{"date":"2024-02-09","current":-2.921549,"twenty":-10.785691,"median":-8.079909,"eighty":-3.801666,"marketCap":11090953},{"date":"2024-02-16","current":-3.323718,"twenty":-10.440311,"median":-7.942961,"eighty":-3.414564,"marketCap":12617692},{"date":"2024-02-23","current":-3.218269,"twenty":-10.164008,"median":-7.897312,"eighty":-3.378041,"marketCap":12217378},{"date":"2024-03-01","current":-3.181749,"twenty":-9.179141,"median":-7.443102,"eighty":-3.218269,"marketCap":12078741},{"date":"2024-03-08","current":-3.378041,"twenty":-9.127872,"median":-4.975763,"eighty":-3.263918,"marketCap":12823915},{"date":"2024-03-15","current":-3.555616,"twenty":-8.855945,"median":-4.679044,"eighty":-3.323718,"marketCap":13498037},{"date":"2024-03-22","current":-3.491707,"twenty":-8.832664,"median":-3.834533,"eighty":-3.332848,"marketCap":13255422},{"date":"2024-03-28","current":-3.149795,"twenty":-8.668692,"median":-3.638241,"eighty":-3.254788,"marketCap":11957434},{"date":"2024-04-05","current":-2.739531,"twenty":-8.426843,"median":-3.539867,"eighty":-3.191975,"marketCap":11784138},{"date":"2024-04-12","current":-2.578785,"twenty":-8.359099,"median":-3.514988,"eighty":-3.15016,"marketCap":11092686},{"date":"2024-04-19","current":-2.356802,"twenty":-8.353987,"median":-3.494218,"eighty":-3.138017,"marketCap":10137824},{"date":"2024-04-26","current":-2.715358,"twenty":-8.317285,"median":-3.457927,"eighty":-2.966103,"marketCap":11680160},{"date":"2024-05-03","current":-2.840249,"twenty":-8.271636,"median":-3.430537,"eighty":-2.908834,"marketCap":12217378},{"date":"2024-05-10","current":-2.751214,"twenty":-8.225986,"median":-3.400866,"eighty":-2.810275,"marketCap":11834394},{"date":"2024-05-17","current":-2.439543,"twenty":-8.198597,"median":-3.378041,"eighty":-2.734696,"marketCap":11265982},{"date":"2024-05-24","current":-2.476318,"twenty":-8.139253,"median":-3.346086,"eighty":-2.649774,"marketCap":11435812},{"date":"2024-05-31","current":-2.456058,"twenty":-8.070779,"median":-3.333761,"eighty":-2.615446,"marketCap":11342250},{"date":"2024-06-07","current":-2.620224,"twenty":-8.03426,"median":-3.293818,"eighty":-2.590871,"marketCap":12100380},{"date":"2024-06-14","current":-2.536364,"twenty":-7.99774,"median":-3.211422,"eighty":-2.574044,"marketCap":11713111},{"date":"2024-06-21","current":-2.409546,"twenty":-7.933831,"median":-3.194759,"eighty":-2.543297,"marketCap":11127455},{"date":"2024-06-28","current":-2.408319,"twenty":-7.915572,"median":-3.18814,"eighty":-2.539819,"marketCap":11121788},{"date":"2024-07-05","current":-2.340001,"twenty":-7.897312,"median":-3.163489,"eighty":-2.517446,"marketCap":10806289},{"date":"2024-07-12","current":-2.148137,"twenty":-7.860792,"median":-3.149795,"eighty":-2.484198,"marketCap":9920249},{"date":"2024-07-15","current":-2.063455,"twenty":-7.842533,"median":-3.149795,"eighty":-2.476543,"marketCap":9529182},{"date":"2024-08-02","current":-1.8,"twenty":-7.824273,"median":-3.149795,"eighty":-2.472639,"marketCap":8312530},{"date":"2024-08-09","current":-1.490993,"twenty":-7.627068,"median":-3.134046,"eighty":-2.438304,"marketCap":6885510},{"date":"2024-08-16","current":-1.275527,"twenty":-7.359564,"median":-3.024259,"eighty":-2.416511,"marketCap":6059653},{"date":"2024-08-23","current":-0.996722,"twenty":-6.536966,"median":-2.921549,"eighty":-2.408074,"marketCap":4735130},{"date":"2024-08-30","current":-1.174958,"twenty":-5.249658,"median":-2.921549,"eighty":-2.362653,"marketCap":5581877},{"date":"2024-09-06","current":-1.375091,"twenty":-4.920984,"median":-2.840249,"eighty":-2.345852,"marketCap":6532648},{"date":"2024-09-13","current":-1.357574,"twenty":-4.774907,"median":-2.7913,"eighty":-2.312486,"marketCap":6449430},{"date":"2024-09-20","current":-1.33918,"twenty":-4.674479,"median":-2.751214,"eighty":-2.26391,"marketCap":6362050},{"date":"2024-09-27","current":-0.556488,"twenty":-4.272766,"median":-2.706294,"eighty":-1.721618,"marketCap":2643710},{"date":"2024-10-04","current":-0.825353,"twenty":-3.907572,"median":-2.663183,"eighty":-1.516044,"marketCap":3921009},{"date":"2024-10-11","current":-0.609011,"twenty":-3.809883,"median":-2.623475,"eighty":-1.448755,"marketCap":2893229},{"date":"2024-10-18","current":-0.543983,"twenty":-3.700324,"median":-2.618669,"eighty":-1.401366,"marketCap":2584301},{"date":"2024-10-25","current":-0.958273,"twenty":-3.624547,"median":-2.598328,"eighty":-1.356698,"marketCap":4552470},{"date":"2024-10-31","current":-0.965548,"twenty":-3.591497,"median":-2.58341,"eighty":-1.330061,"marketCap":4587034},{"date":"2024-11-08","current":-0.186042,"twenty":-3.543017,"median":-2.570883,"eighty":-1.290658,"marketCap":883831},{"date":"2024-11-15","current":-0.272307,"twenty":-3.520466,"median":-2.545057,"eighty":-1.259215,"marketCap":1293652},{"date":"2024-11-22","current":-1.912035,"twenty":-3.514988,"median":-2.532982,"eighty":-1.195453,"marketCap":10456757},{"date":"2024-11-29","current":-0.970216,"twenty":-3.514075,"median":-2.507089,"eighty":-1.176604,"marketCap":5306027},{"date":"2024-12-06","current":-0.979681,"twenty":-3.507684,"median":-2.495456,"eighty":-1.057426,"marketCap":5357793},{"date":"2024-12-13","current":-1.055406,"twenty":-3.495725,"median":-2.476318,"eighty":-1.052022,"marketCap":5771922},{"date":"2024-12-20","current":-1.320411,"twenty":-3.487233,"median":-2.449166,"eighty":-1.053364,"marketCap":7221213},{"date":"2024-12-27","current":-1.354124,"twenty":-3.469339,"median":-2.436446,"eighty":-1.055406,"marketCap":7405585},{"date":"2025-01-03","current":-1.393455,"twenty":-3.460209,"median":-2.417636,"eighty":-1.071656,"marketCap":7620685},{"date":"2025-01-10","current":-1.18556,"twenty":-3.45108,"median":-2.415433,"eighty":-1.087177,"marketCap":6483728},{"date":"2025-01-17","current":-1.208035,"twenty":-3.441037,"median":-2.409546,"eighty":-1.102066,"marketCap":6606642},{"date":"2025-01-24","current":-1.112516,"twenty":-3.431907,"median":-2.407092,"eighty":-1.109145,"marketCap":6084256},{"date":"2025-01-31","current":-0.955191,"twenty":-3.419127,"median":-2.368422,"eighty":-1.085209,"marketCap":5223856},{"date":"2025-02-07","current":-1.039472,"twenty":-3.407716,"median":-2.352273,"eighty":-1.05223,"marketCap":5684785},{"date":"2025-02-14","current":-0.955191,"twenty":-3.391736,"median":-2.340001,"eighty":-1.033105,"marketCap":5223856},{"date":"2025-02-21","current":-0.915859,"twenty":-3.378041,"median":-2.326586,"eighty":-0.998824,"marketCap":5008756},{"date":"2025-02-28","current":-0.668633,"twenty":-3.378041,"median":-2.304429,"eighty":-0.984457,"marketCap":3656699},{"date":"2025-03-07","current":-0.406293,"twenty":-3.378041,"median":-2.256137,"eighty":-0.973171,"marketCap":2221982},{"date":"2025-03-14","current":-0.413918,"twenty":-3.37165,"median":-2.063455,"eighty":-0.968145,"marketCap":2263682},{"date":"2025-03-21","current":-0.675785,"twenty":-3.34426,"median":-1.851285,"eighty":-0.96081,"marketCap":3695808},{"date":"2025-03-28","current":-0.778466,"twenty":-3.336318,"median":-1.604046,"eighty":-0.955191,"marketCap":4257365},{"date":"2025-04-04","current":-0.500407,"twenty":-3.333578,"median":-1.540289,"eighty":-0.934537,"marketCap":3125408},{"date":"2025-04-11","current":-0.363417,"twenty":-3.331022,"median":-1.490993,"eighty":-0.836712,"marketCap":2269810},{"date":"2025-04-17","current":-0.292093,"twenty":-3.323718,"median":-1.4582,"eighty":-0.778466,"marketCap":1824333},{"date":"2025-04-25","current":-0.251335,"twenty":-3.263918,"median":-1.443055,"eighty":-0.679871,"marketCap":1569775},{"date":"2025-05-01","current":-0.25926,"twenty":-3.227399,"median":-1.420416,"eighty":-0.675686,"marketCap":1619272}],"updateTime":1746210871191}}}